Felix Weiland, Boehringer Ingelheim Microparts
Felix Weiland
Director Device Technology -Device Operations
Boehringer Ingelheim Microparts

Felix is a pharmacist by training with a PhD in pharmacology. In 2006, he joined Boehringer Ingelheim as a trainee, focusing on launch and transfer activities of inhalative products. He took over different roles at BI microParts for development of inhalation devices as QA Head, senior project manager and lab head for design engineering. In 2010, he joined the Ger¬resheimer Group as a QC head and later on quality director for large-scale manufacturing of sterile primary packaging components, i.e.RTF®- syringes and insulin cartridges. In 2015, he returned to Boehringer Ingelheim to implement structures for life cycle management of the Respimat® Plat¬form Technology, including ownership of design history files for existing products and launching the new Respimat Reusable® in Europe in 2018. Currently he is the director of Device Technology in operations. He is responsible for a matrix organization that includes project management, design verification laboratories, clinical trial supply, design engineering, design control, process technology and data science approaches for life cycle of devices in operations.